For: | Pirola CJ, Salatino A, Sookoian S. Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system. World J Gastroenterol 2021; 27(4): 305-320 [PMID: 33584064 DOI: 10.3748/wjg.v27.i4.305] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i4/305.htm |
Number | Citing Articles |
1 |
Julia Kozlitina, Silvia Sookoian. Global Epidemiological Impact of PNPLA3 I148M on Liver Disease. Liver International 2024; doi: 10.1111/liv.16123
|
2 |
Carlos J. Pirola, Silvia Sookoian. PNPLA3 and COVID‐19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system. Liver International 2021; 41(11): 2801 doi: 10.1111/liv.15043
|
3 |
Silvia Sookoian, Carlos J. Pirola. Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response. Clinical and Molecular Hepatology 2023; 29(Suppl): S184 doi: 10.3350/cmh.2022.0318
|
4 |
Carlos J. Pirola, Silvia Sookoian. Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications. Current Opinion in Lipidology 2022; 33(2): 95 doi: 10.1097/MOL.0000000000000814
|
5 |
Carlos J. Pirola, Silvia Sookoian. Editorial: NAFLD, chronic kidney disease, and pleiotropy—Why is PNPLA3 omnipresent?. Alimentary Pharmacology & Therapeutics 2023; 57(10): 1180 doi: 10.1111/apt.17491
|
6 |
Marica Meroni, Paola Dongiovanni. PNPLA3 rs738409 Genetic Variant Inversely Correlates with Platelet Count, Thereby Affecting the Performance of Noninvasive Scores of Hepatic Fibrosis. International Journal of Molecular Sciences 2023; 24(20): 15046 doi: 10.3390/ijms242015046
|
7 |
Susan Yeyeodu, Donia Hanafi, Kenisha Webb, Nikia A. Laurie, K. Sean Kimbro. Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease. Frontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1286979
|